Estrace Cream
Product Images NDC 0430-3754

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Estrace (NDC 0430-3754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Structural Formula For Estrace (estradiol Vaginal Cream, Usp, 0.01%) Contains 0.1 mg Estradiol In A Nonliquefying Base Containing Purified Water, Propylene Glycol, Stearyl Alcohol, White Ceresin Wax, Mono- And Di-glycerides, Hypromellose 2208 (4000 Cps), Sodium Lauryl Sulfate, Methylparaben, Edetate Di-sodium And Tertiary-butylhydroquinone. Estradiol Is Chemically Described As Estra-1,3,5(10)-triene-3, 17(beta)-diol. It Has An Empirical Formula Of C18h24o2 And Molecular Weight Of 272.37. (Estrace Cream 01)

The Structural Formula For Estrace (estradiol Vaginal Cream, Usp, 0.01%) Contains 0.1 mg Estradiol In A Nonliquefying Base Containing Purified Water, Propylene Glycol, Stearyl Alcohol, White Ceresin Wax, Mono- And Di-glycerides, Hypromellose 2208 (4000 Cps), Sodium Lauryl Sulfate, Methylparaben, Edetate Di-sodium And Tertiary-butylhydroquinone. Estradiol Is Chemically Described As Estra-1,3,5(10)-triene-3, 17(beta)-diol. It Has An Empirical Formula Of C18h24o2 And Molecular Weight Of 272.37. (Estrace Cream 01)
FDA Label Image

Table 2 -relative And Absolute Risk Seen In The Estrogen Plus Progestin Substudy Of Whi At An Average Of 5.6 Years A,b (Estrace Cream 02)

Table 2 -relative And Absolute Risk Seen In The Estrogen Plus Progestin Substudy Of Whi At An Average Of 5.6 Years A,b (Estrace Cream 02)
The text describes the results of various studies and the associated risks for different medical conditions such as non-fatal MI, ischemic stroke, endometrial cancer, hip fracture, and overall mortality. The results are based on centrally adjudicated data, and the text indicates which conditions are not included in the global index. Confidence intervals are not adjusted for il looks and multiple comparisons. Information on the source publications can be viewed at www.nhibi.nih.gov/whi.*
FDA Label Image

Principal Display Panelndc 0430-3754-14estrace Cream(estradiol Vaginal Cream, Usp, 0.01%)rx Onlynet Wt 1 ½ Oz (42.5 G) (Estrace Cream 03)

Principal Display Panelndc 0430-3754-14estrace Cream(estradiol Vaginal Cream, Usp, 0.01%)rx Onlynet Wt 1 ½ Oz (42.5 G) (Estrace Cream 03)
FDA Label Image

Estrace Cream 04

Estrace Cream 04

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.